Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |